Member Exclusive News

Potential drug target for cardiomyopathy identified

A team from the Stanford University School of Medicine (CA, USA) have reported that a surge in the platelet-derived growth factor pathway could be the cause of abnormal cardiac rhythms experienced by patients with cardiomyopathy. They also believe that this could be treated with existing drugs.

Go to the profile of Rhiannon Finnie
Jul 18, 2019

Please sign in or register for FREE

No comments yet.